MedTrace Logo

Effect of Positive Airway Pressure Therapy on Hospitalization and Mortality in SDB Patients With Comorbid Chronic Obstructive Pulmonary Disease (COPD) or/and Heart Failure (HF)

NCT02923505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 383

Last updated 2018-10-29

No results posted yet for this study

Summary

The aim of the study is to test the hypothesis that treatment of sleep disordered breathing (SDB) in patients with comorbid chronic obstructive pulmonary disease (COPD) and/or heart failure (HF) with positive airway pressure (PAP) is associated with reduced risk for hospitalizations and death, lower health care utilization, and greater cost-effectiveness.

Conditions

  • Sleep-Disordered Breathing
  • Pulmonary Disease, Chronic Obstructive
  • Heart Failure

Interventions

PROCEDURE

polygraphy or polysomnography

Sponsors & Collaborators

  • Philips Respironics

    collaborator INDUSTRY

  • Wissenschaftliches Institut Bethanien e.V

    lead OTHER

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-16
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Denmark
  • France
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02923505 on ClinicalTrials.gov